Fujifilm’s Avigan Set For Ebola Trial
This article was originally published in PharmAsia News
Executive Summary
Fujifilm has decided to ramp up production of a novel oral antiviral drug to prepare for potential use in Ebola patients following promising signs of activity and amid plans for an African clinical trial in the hemorrhagic disease.